11/17/11 CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation GL
06/17/06 CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results GL
03/17/03 CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation GL
02/17/02 Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation GL
20/17/20 CombiMatrix to Present New Data from a Large-Scale Analysis of Genomic Abnormalities Impacting Multiple Stages of Human Growth and Development Starting from Conception through Childhood at the American Society of Human Genetics Annual Meeting GL
25/17/25 CombiMatrix Sets Record Date and Special Stockholders Meeting Date Regarding Proposed Merger with Invitae GL
03/17/03 CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results GL
01/17/01 CombiMatrix Enters Into Merger Agreement with Invitae Corporation to be Acquired for $33 Million in Invitae Common Stock GL
22/17/22 CombiMatrix to Present at Upcoming Investor Conferences GL
05/17/05 CombiMatrix Corporation Reports First Quarter 2017 Financial and Operating Results GL
27/17/27 CombiMatrix Corporation to Release 2017 First Quarter Financial Results on May 4, 2017 GL
01/17/01 CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors GL
23/17/23 CombiMatrix Corporation Reports 2016 Fourth Quarter and Full Year Financial and Operating Results GL
15/17/15 CombiMatrix Corporation to Release 2016 Fourth Quarter and Full Year Financial Results on February 22, 2017 GL
08/17/08 CombiMatrix to Present at 2nd Annual Disruptive Growth & Healthcare Conference GL
02/17/02 CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board GL
20/17/20 CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss GL
29/16/29 CombiMatrix : Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health PU
29/16/29 CombiMatrix’s Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health GL
02/16/02 CombiMatrix Corporation Reports Third Quarter 2016 Financial and Operating Results GL
26/16/26 CombiMatrix Corporation to Release 2016 Third Quarter Financial Results on November 2, 2016 GL
08/16/08 CombiMatrix to Present at September Investment Conferences GL
16/16/16 CombiMatrix Notes Decision by Health Care Service Corporation to Reimburse for Recurrent Pregnancy Loss Testing GL
10/16/10 CombiMatrix Announces Distribution Agreement with Universal Diagnostic Laboratories for Miscarriage Analysis Testing GL
04/16/04 CombiMatrix Corporation Reports Second Quarter 2016 Financial and Operating Results GL
No results match your criteria
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!